| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 瓜子金皂苷XXXV; Polygalasaponin XXXV | CFN95176 | 184479-28-5 | C63H98O31 = 1351.5 | 5mg | QQ客服：1457312923 |
| 儿茶酚; Caulophyllogenin | CFN91135 | 52936-64-8 | C30H48O5 = 488.7 | 5mg | QQ客服：1457312923 |
| Randialic acid B; Randialic acid B | CFN91138 | 14021-14-8 | C30H46O3 = 454.7 | 5mg | QQ客服：2159513211 |
| 地榆皂苷元; Sanguisorbigenin | CFN91139 | 6812-98-2 | C30H46O3 = 454.7 | 5mg | QQ客服：1413575084 |
| 三七皂苷R4; Notoginsenoside R4 | CFN91142 | 87741-77-3 | C59H100O27 = 1241.4 | 5mg | QQ客服：2056216494 |
| Arjunetin; Arjunetin | CFN91151 | 31297-79-7 | C36H58O10 = 650.9 | 5mg | QQ客服：2056216494 |
| 青葙苷J; Celosin J | CFN91152 | 1623405-29-7 | C58H90O28 = 1235.3 | 5mg | QQ客服：2056216494 |
| 金盏花苷E; Calenduloside E | CFN91169 | 26020-14-4 | C36H56O9 = 632.8 | 10mg | QQ客服：1457312923 |
| 白头翁皂苷D; Pulsatillasaponin D | CFN80130 | 68027-15-6 | C47H76O17 = 913.1 | 5mg | QQ客服：215959384 |
| 3,29-二苯甲酰基栝楼仁二醇; 3,29-O-Dibenzoyloxykarounidiol | CFN91175 | 389122-01-4 | C44H56O4 = 648.9 | 10mg | QQ客服：2159513211 |
| 人参皂苷Rd2; Ginsenoside Rd2 (Quinquenoside L10) | CFN95231 | 83480-64-2 | C47H80O17 = 917.2 | 10mg | QQ客服：215959384 |
| 人参皂苷MC; Ginsenoside MC | CFN95232 | 175484-06-7 | C41H70O12 = 755.0 | 10mg | QQ客服：3257982914 |
| 假马齿苋皂苷IV; Bacopaside IV | CFN91182 | 155545-03-2 | C41H66O13 = 767.0 | 5mg | QQ客服：1457312923 |
| Sutherlandioside B; Sutherlandioside B | CFN70255 | 1055329-47-9 | C36H60O10 = 652.9 | 5mg | QQ客服：2159513211 |
| Sutherlandioside D; Sutherlandioside D | CFN70256 | 1055329-49-1 | C36H58O9 = 634.9 | 5mg | QQ客服：2159513211 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)